Cardiopulmonary risk model for patients with chronic obstructive pulmonary disease

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/105273
• EU PAS number:
  EUPAS105272
• Study ID:
  105273
• Official title and acronym:
  Cardiopulmonary risk model for patients with chronic obstructive pulmonary disease
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  An observational, historical cohort study to construct a risk model that predicts major cardiopulmonary events amongst patients with chronic obstructive pulmonary disease using the OPCRD database
• Study status:
  Ongoing

Research institution and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 05/10/2022

Actual: 05/10/2022

Study start date

Planned: 21/10/2022

Actual: 21/10/2022

Date of final study report

Planned: 31/07/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

AstraZeneca

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable